肝移植合并症指数(LTCI):整合门诊移植前因素以识别移植后死亡风险升高患者的复合指数
8中心前瞻性FrAILT研究纳入2012至2022年1472例成人首次 deceased donor 肝移植受者,构建包含衰弱、冠心病、肝细胞癌、肾功能不全和糖尿病的LTCI。低、中、高危组3年移植后死亡率分别为93%、87%、80%,中危(HR 2.23)和高危(HR 2.78)与3年移植后死亡相关。
要点
- LTCI由衰弱、冠心病、肝细胞癌、肾功能不全和糖尿病5项移植前因素构成。
- 低、中、高危LTCI组3年移植后死亡率分别为93%、87%、80%。
- 调整供体因素后,中危(HR 2.23)和高危(HR 2.78)与3年移植后死亡相关。
核心结论
- LTCI包含5项移植前临床参数,可有效识别移植后死亡风险升高的患者。
- 将衰弱与其他合并症整合,LTCI可帮助提供者权衡移植风险与获益并规范移植候选者选择。
研究设计与样本
- 8中心前瞻性功能性评估在肝移植(FrAILT)研究,纳入2012至2022年成人首次 deceased donor 肝移植受者。
- 衰弱采用肝脏衰弱指数(LFI≥4.5定义为衰弱)测量,候选变量包括人口学、实验室检查和合并症。
- 采用Cox比例风险回归联合最佳子集选择识别3年移植后死亡的危险因素,最终模型基于赤池信息准则和临床实用性选择。
主要发现
- 1472例肝移植受者中290例(20%)为衰弱。
- 衰弱患者3年移植后死亡率高于非衰弱患者(13% vs 8%;p=0.03)。
- 低危、中危、高危LTCI组3年移植后死亡率分别为93%、87%、80%。
- 调整供体因素(年龄和循环死亡后捐献)后,中危(HR 2.23,95%CI 1.46-3.40;p<0.001)和高危(HR 2.78,95%CI 1.67-4.64;p<0.001)状态与3年移植后死亡相关。
关键数值与推荐
- LTCI最终包含5个变量:衰弱、冠心病、肝细胞癌、肾功能不全和糖尿病。
- 衰弱定义为肝脏衰弱指数(LFI)≥4.5。
- 中危LTCI状态与3年移植后死亡的HR为2.23(95%CI 1.46-3.40;p<0.001)。
- 高危LTCI状态与3年移植后死亡的HR为2.78(95%CI 1.67-4.64;p<0.001)。
临床怎么用
- 作者认为LTCI可帮助提供者更好地权衡相对移植风险与获益并规范移植候选者选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Frailty is strongly associated with mortality after liver transplantation. However, national guidelines discourage its use as a sole reason to decline a patient for liver transplantation, as some frail patients have acceptable outcomes. We aimed to develop a composite index, the Liver Transplant Comorbidity Index (LTCI), integrating frailty and other comorbidities, as a risk factor for longer-term (3-year) posttransplant mortality. APPROACH AND RESULTS: This 8-center prospective Functional Assessment in Liver Transplantation (FrAILT) Study included adult recipients of a primary deceased donor liver transplant from 2012 to 2022. Frailty was measured using the Liver Frailty Index (LFI ≥4.5=frail). Other candidate variables included demographics, laboratories, and comorbidities. Cox proportional hazards regression with best subset selection was used to identify risk factors of 3-year posttransplant death. The final model was selected based on Akaike Information Criterion and clinical pragmatism. Of 1472 liver transplant recipients, 290 (20%) were frail. Three-year posttransplant mortality was higher in frail versus non-frail patients (13% vs. 8%; p =0.03). The final LTCI included 5 variables: frailty, coronary artery disease, HCC, renal dysfunction, and diabetes. Three-year posttransplant mortality in low-risk, moderate-risk, and high-risk LTCI groups was 93%, 87%, and 80%, respectively. In multivariable analysis, after adjusting for donor factors (age and donation after circulatory death), both moderate-risk (HR: 2.23, 95% CI: 1.46-3.40; p <0.001) and high-risk (HR: 2.78, 95% CI: 1.67-4.64; p <0.001) status were associated with 3-year posttransplant mortality. CONCLUSIONS: The LTCI, comprising 5 pretransplant clinical parameters, effectively identifies patients at increased risk of posttransplant mortality. By integrating frailty in the context of other comorbidities, the LTCI can help providers better weigh the relative transplant risks and benefits and standardize the selection of transplant candidates.
引用
- Lai JC, Shui AM, Molinari M, et al. The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality. Hepatology. 2025. PMID: 40132167. doi:10.1097/HEP.0000000000001320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。